| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Experimental Studies |
Clinical Research Center Thyroid Tumor Biology Research Group, University of Wales College of Medicine, Cardiff, United Kingdom CF4 4XN
Address all correspondence and requests for reprints to: Prof. D. Wynford-Thomas, Clinical Research Center Thyroid Tumor Biology Research Group, University of Wales College of Medicine, Heath Park, Cardiff, United Kingdom CF4 4XN.
Point mutations of the gsp protooncogene (encoding the
-subunit of the Gs protein) that
constitutively activate the cAMP signaling pathway are a common feature
of and a plausible causative mechanism for thyroid hyperfunctioning
adenomas (hot nodules). To investigate the extent to which mutant
gsp acting alone can induce proliferation of thyroid
follicular cells, we generated an amphotropic retroviral vector (based
on the pBABE-neo plasmid and psi-CRIP packaging line) to
permit stable introduction of a hemagglutinin-tagged
Gln227
Leu mutant gsp gene into normal human
thyrocytes in vitro. The biological activity of the
vector was confirmed by detection of HA-tagged Gsp protein expression
and induction of cAMP synthesis in selected target cells. Normal human
thyroid follicular cells in primary monolayer culture were infected
with the gsp retroviral vector or with corresponding vectors
expressing mutant H-ras or neo only as
positive and negative controls, respectively. Although, as before,
mutant ras generated 1020 well differentiated epithelial
colonies/dish of 105 infected cells, with an average
lifespan of 1520 population doublings, only small groups of no more
than 1550 differentiated thyrocytes were observed with the
gsp vector. In addition to standard conditions (10% FCS),
infections were performed in reduced serum (1% FCS, TSH, and insulin),
in the presence of isobutylylmethylxanthine, or in the presence of
agents capable of closing gap junctions, with no significant difference
in outcome. Although little or no proliferative response was observed
regardless of the conditions, there was clear evidence of morphological
response (rearrangement of the actin cytoskeleton and increased cell
size). The results suggest that gsp mutation may not be a
sufficient proliferogenic stimulus by itself to account for hot nodule
formation.
This article has been cited by other articles:
![]() |
M. Derwahl, M. Broecker, and Z. Kraiem Thyrotropin May Not Be the Dominant Growth Factor in Benign and Malignant Thyroid Tumors J. Clin. Endocrinol. Metab., March 1, 1999; 84(3): 829 - 834. [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |